Business · 17/11/20261 min read
Cradle's Antibody Discovery Platform for Autoimmune Diseases Supports Scientific Mission of argenx
Summary
Builds on successful results from initial discovery programs as argenx broadens use of Cradle's platform to more scientists and discovery programs AMSTERDAM, Nov. 17, 2026 — Cradle, today announced that argenx is expanding use of Cradle's end-to-end AI-driven protein...